Report Detail

Medical Devices & Consumables Global Medical Heparin Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4530355
  • |
  • 26 April, 2023
  • |
  • Global
  • |
  • 107 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Medical Heparin market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Heparin is an anticoagulant drug commonly used to prevent and treat thrombotic diseases. It is a natural polysaccharide substance secreted by liver cells and lung cells, which has the effect of inhibiting thrombin and preventing blood from clotting in blood vessels.
Heparin is usually administered by intravenous or subcutaneous injection. It is widely used in cardiac surgery, hemodialysis, treatment of thrombotic diseases, and other situations that require anticoagulation. Unlike other anticoagulants, the effect of heparin is reversible, which makes it very useful in situations where anticoagulation needs to be quickly stopped, such as during surgery.
However, the use of heparin also carries some risks, such as bleeding and other side effects. Therefore, before using heparin, doctors will assess the risks and benefits based on the patient's specific condition and develop a personalized treatment plan.
This report is a detailed and comprehensive analysis for global Medical Heparin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Molecular Weight and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Medical Heparin market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Medical Heparin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Medical Heparin market size and forecasts, by Molecular Weight and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2018-2029
Global Medical Heparin market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Medical Heparin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Medical Heparin market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hepalink, Changshan Pharm, Pfizer, Bioberica and Criticine Care, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Medical Heparin market is split by Molecular Weight and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Molecular Weight, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Molecular Weight
High Molecular Weight Heparin (HMWH)
Low Molecular Weight Heparin (LMWH)
Market segment by Application
Treatment of Thrombotic Diseases
Postoperative Rehabilitation
Others
Major players covered
Hepalink
Changshan Pharm
Pfizer
Bioberica
Criticine Care
SmithField BioScience
Sanofi
Fresenius Kabi
Aspen Pharmacare
LEO Pharma
Baxter Healthcare
Cardinal Health
SwissPAR
Fierce Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Medical Heparin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medical Heparin, with price, sales, revenue and global market share of Medical Heparin from 2018 to 2023.
Chapter 3, the Medical Heparin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical Heparin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Molecular Weight and application, with sales market share and growth rate by molecular weight, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Medical Heparin market forecast, by regions, molecular weight and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Heparin.
Chapter 14 and 15, to describe Medical Heparin sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Medical Heparin
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Molecular Weight
    • 1.3.1 Overview: Global Medical Heparin Consumption Value by Molecular Weight: 2018 Versus 2022 Versus 2029
    • 1.3.2 High Molecular Weight Heparin (HMWH)
    • 1.3.3 Low Molecular Weight Heparin (LMWH)
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Medical Heparin Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Treatment of Thrombotic Diseases
    • 1.4.3 Postoperative Rehabilitation
    • 1.4.4 Others
  • 1.5 Global Medical Heparin Market Size & Forecast
    • 1.5.1 Global Medical Heparin Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Medical Heparin Sales Quantity (2018-2029)
    • 1.5.3 Global Medical Heparin Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Hepalink
    • 2.1.1 Hepalink Details
    • 2.1.2 Hepalink Major Business
    • 2.1.3 Hepalink Medical Heparin Product and Services
    • 2.1.4 Hepalink Medical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Hepalink Recent Developments/Updates
  • 2.2 Changshan Pharm
    • 2.2.1 Changshan Pharm Details
    • 2.2.2 Changshan Pharm Major Business
    • 2.2.3 Changshan Pharm Medical Heparin Product and Services
    • 2.2.4 Changshan Pharm Medical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Changshan Pharm Recent Developments/Updates
  • 2.3 Pfizer
    • 2.3.1 Pfizer Details
    • 2.3.2 Pfizer Major Business
    • 2.3.3 Pfizer Medical Heparin Product and Services
    • 2.3.4 Pfizer Medical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Pfizer Recent Developments/Updates
  • 2.4 Bioberica
    • 2.4.1 Bioberica Details
    • 2.4.2 Bioberica Major Business
    • 2.4.3 Bioberica Medical Heparin Product and Services
    • 2.4.4 Bioberica Medical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Bioberica Recent Developments/Updates
  • 2.5 Criticine Care
    • 2.5.1 Criticine Care Details
    • 2.5.2 Criticine Care Major Business
    • 2.5.3 Criticine Care Medical Heparin Product and Services
    • 2.5.4 Criticine Care Medical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Criticine Care Recent Developments/Updates
  • 2.6 SmithField BioScience
    • 2.6.1 SmithField BioScience Details
    • 2.6.2 SmithField BioScience Major Business
    • 2.6.3 SmithField BioScience Medical Heparin Product and Services
    • 2.6.4 SmithField BioScience Medical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 SmithField BioScience Recent Developments/Updates
  • 2.7 Sanofi
    • 2.7.1 Sanofi Details
    • 2.7.2 Sanofi Major Business
    • 2.7.3 Sanofi Medical Heparin Product and Services
    • 2.7.4 Sanofi Medical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Sanofi Recent Developments/Updates
  • 2.8 Fresenius Kabi
    • 2.8.1 Fresenius Kabi Details
    • 2.8.2 Fresenius Kabi Major Business
    • 2.8.3 Fresenius Kabi Medical Heparin Product and Services
    • 2.8.4 Fresenius Kabi Medical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Fresenius Kabi Recent Developments/Updates
  • 2.9 Aspen Pharmacare
    • 2.9.1 Aspen Pharmacare Details
    • 2.9.2 Aspen Pharmacare Major Business
    • 2.9.3 Aspen Pharmacare Medical Heparin Product and Services
    • 2.9.4 Aspen Pharmacare Medical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Aspen Pharmacare Recent Developments/Updates
  • 2.10 LEO Pharma
    • 2.10.1 LEO Pharma Details
    • 2.10.2 LEO Pharma Major Business
    • 2.10.3 LEO Pharma Medical Heparin Product and Services
    • 2.10.4 LEO Pharma Medical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 LEO Pharma Recent Developments/Updates
  • 2.11 Baxter Healthcare
    • 2.11.1 Baxter Healthcare Details
    • 2.11.2 Baxter Healthcare Major Business
    • 2.11.3 Baxter Healthcare Medical Heparin Product and Services
    • 2.11.4 Baxter Healthcare Medical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Baxter Healthcare Recent Developments/Updates
  • 2.12 Cardinal Health
    • 2.12.1 Cardinal Health Details
    • 2.12.2 Cardinal Health Major Business
    • 2.12.3 Cardinal Health Medical Heparin Product and Services
    • 2.12.4 Cardinal Health Medical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Cardinal Health Recent Developments/Updates
  • 2.13 SwissPAR
    • 2.13.1 SwissPAR Details
    • 2.13.2 SwissPAR Major Business
    • 2.13.3 SwissPAR Medical Heparin Product and Services
    • 2.13.4 SwissPAR Medical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 SwissPAR Recent Developments/Updates
  • 2.14 Fierce Pharma
    • 2.14.1 Fierce Pharma Details
    • 2.14.2 Fierce Pharma Major Business
    • 2.14.3 Fierce Pharma Medical Heparin Product and Services
    • 2.14.4 Fierce Pharma Medical Heparin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Fierce Pharma Recent Developments/Updates

3 Competitive Environment: Medical Heparin by Manufacturer

  • 3.1 Global Medical Heparin Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Medical Heparin Revenue by Manufacturer (2018-2023)
  • 3.3 Global Medical Heparin Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Medical Heparin by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Medical Heparin Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Medical Heparin Manufacturer Market Share in 2022
  • 3.5 Medical Heparin Market: Overall Company Footprint Analysis
    • 3.5.1 Medical Heparin Market: Region Footprint
    • 3.5.2 Medical Heparin Market: Company Product Type Footprint
    • 3.5.3 Medical Heparin Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Medical Heparin Market Size by Region
    • 4.1.1 Global Medical Heparin Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Medical Heparin Consumption Value by Region (2018-2029)
    • 4.1.3 Global Medical Heparin Average Price by Region (2018-2029)
  • 4.2 North America Medical Heparin Consumption Value (2018-2029)
  • 4.3 Europe Medical Heparin Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Medical Heparin Consumption Value (2018-2029)
  • 4.5 South America Medical Heparin Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Medical Heparin Consumption Value (2018-2029)

5 Market Segment by Molecular Weight

  • 5.1 Global Medical Heparin Sales Quantity by Molecular Weight (2018-2029)
  • 5.2 Global Medical Heparin Consumption Value by Molecular Weight (2018-2029)
  • 5.3 Global Medical Heparin Average Price by Molecular Weight (2018-2029)

6 Market Segment by Application

  • 6.1 Global Medical Heparin Sales Quantity by Application (2018-2029)
  • 6.2 Global Medical Heparin Consumption Value by Application (2018-2029)
  • 6.3 Global Medical Heparin Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Medical Heparin Sales Quantity by Molecular Weight (2018-2029)
  • 7.2 North America Medical Heparin Sales Quantity by Application (2018-2029)
  • 7.3 North America Medical Heparin Market Size by Country
    • 7.3.1 North America Medical Heparin Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Medical Heparin Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Medical Heparin Sales Quantity by Molecular Weight (2018-2029)
  • 8.2 Europe Medical Heparin Sales Quantity by Application (2018-2029)
  • 8.3 Europe Medical Heparin Market Size by Country
    • 8.3.1 Europe Medical Heparin Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Medical Heparin Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Medical Heparin Sales Quantity by Molecular Weight (2018-2029)
  • 9.2 Asia-Pacific Medical Heparin Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Medical Heparin Market Size by Region
    • 9.3.1 Asia-Pacific Medical Heparin Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Medical Heparin Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Medical Heparin Sales Quantity by Molecular Weight (2018-2029)
  • 10.2 South America Medical Heparin Sales Quantity by Application (2018-2029)
  • 10.3 South America Medical Heparin Market Size by Country
    • 10.3.1 South America Medical Heparin Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Medical Heparin Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Medical Heparin Sales Quantity by Molecular Weight (2018-2029)
  • 11.2 Middle East & Africa Medical Heparin Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Medical Heparin Market Size by Country
    • 11.3.1 Middle East & Africa Medical Heparin Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Medical Heparin Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Medical Heparin Market Drivers
  • 12.2 Medical Heparin Market Restraints
  • 12.3 Medical Heparin Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Medical Heparin and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Medical Heparin
  • 13.3 Medical Heparin Production Process
  • 13.4 Medical Heparin Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Medical Heparin Typical Distributors
  • 14.3 Medical Heparin Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Medical Heparin. Industry analysis & Market Report on Medical Heparin is a syndicated market report, published as Global Medical Heparin Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Medical Heparin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,686.56
    4,029.84
    5,373.12
    3,198.12
    4,797.18
    6,396.24
    529,203.60
    793,805.40
    1,058,407.20
    292,876.80
    439,315.20
    585,753.60
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report